← Leaderboards
Jae U Jung
Cleveland Clinic Lerner Com-Cwru
$74,270,295
Attributed
$76,972,249
Total exposure
62
Grants
41
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$94,288,013 · 64
By mechanism
R01$51,313,661 · 19
P01$16,848,041 · 9
U19$12,025,898 · 3
R35$6,123,545 · 1
P51$2,299,555 · 25
U01$1,962,036 · 1
Top collaborators
- Karin Nielsen6 shared
- Genhong Cheng5 shared
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralVirusIn VivoHuman Herpesvirus 8InfectionMediatingPathogenesisCellsGenesMolecularIn VitroBaseProteinsMouse ModelKaposi SarcomaPathway InteractionsImmuneMutantAffectVirus DiseasesRecombinantsGenomeAnimal ModelSignal Transduction
Grant awards (200)
Development of three KSHV vaccine platforms and chimeric MHV68-K-G for in vivo mouse infection study$972,133
U01 · FY2025 · CA · contact PI
KSHV-mediated metabolic reprogramming for LANA expression and viral persistency$675,416
R01 · FY2025 · AI · contact PI
Reassortment of Bunyavirus in ticks and animal models$577,845
R01 · FY2025 · AI · contact PI
Development of three KSHV vaccine platforms and chimeric MHV68-K-G for in vivo mouse infection study$989,903
U01 · FY2024 · CA · contact PI
KSHV-mediated metabolic reprogramming for LANA expression and viral persistency$675,416
R01 · FY2024 · AI · contact PI
Reassortment of Bunyavirus in ticks and animal models$577,846
R01 · FY2024 · AI · contact PI
Tickborne SFTS Virus Vaccine Development$564,500
R01 · FY2024 · AI · contact PI
Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor$490,912
R01 · FY2024 · CA · contact PI
KSHV Epigenetic Regulation$422,538
R01 · FY2024 · DE · contact PI
Reassortment of Bunyavirus in ticks and animal models$577,846
R01 · FY2023 · AI · contact PI
Tickborne SFTS Virus Vaccine Development$564,500
R01 · FY2023 · AI · contact PI
Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor$490,912
R01 · FY2023 · CA · contact PI
KSHVmediated regulation of proline metabolism$462,172
R01 · FY2023 · DE · contact PI
KSHV Epigenetic Regulation$431,161
R01 · FY2023 · DE · contact PI
Infant Immunologic and Neurologic Development following Maternal Infection in Pregnancy during Recent Epidemics$369,974
R56 · FY2023 · AI
Molecular Basis of KSHV oncogenesis$853,521
R35 · FY2022 · CA · contact PI
Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV$750,035
R01 · FY2022 · AI
SFTSV nonstructural protein NSs-mediated immunopathogenesis$604,163
R01 · FY2022 · AI · contact PI
Reassortment of Bunyavirus in ticks and animal models$593,096
R01 · FY2022 · AI · contact PI
Tickborne SFTS Virus Vaccine Development$564,500
R01 · FY2022 · AI · contact PI
Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor$490,912
R01 · FY2022 · CA · contact PI
KSHVmediated regulation of proline metabolism$463,004
R01 · FY2022 · DE · contact PI
KSHV Epigenetic Regulation$431,161
R01 · FY2022 · DE · contact PI
Molecular Basis of KSHV oncogenesis$872,907
R35 · FY2021 · CA · contact PI
Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV$747,874
R01 · FY2021 · AI
SFTSV nonstructural protein NSs-mediated immunopathogenesis$604,163
R01 · FY2021 · AI · contact PI
Tickborne SFTS Virus Vaccine Development$564,500
R01 · FY2021 · AI · contact PI
Infection and Rapid Transmission of SARS-C0V-2 in Ferrets$532,961
R01 · FY2021 · AI · contact PI
Infection and Rapid Transmission of SARS-C0V-2 in Ferrets$519,707
R01 · FY2021 · AI · contact PI
Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor$490,912
R01 · FY2021 · CA · contact PI
KSHVmediated regulation of proline metabolism$479,059
R01 · FY2021 · DE · contact PI
KSHV Epigenetic Regulation$431,161
R01 · FY2021 · DE · contact PI
Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV$750,411
R01 · FY2020 · AI
SFTSV nonstructural protein NSs-mediated immunopathogenesis$619,413
R01 · FY2020 · AI · contact PI
Molecular Basis of KSHV oncogenesis$610,219
R35 · FY2020 · CA · contact PI
Tickborne SFTS Virus Vaccine Development$595,000
R01 · FY2020 · AI · contact PI
Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor$490,912
R01 · FY2020 · CA · contact PI
KSHV Epigenetic Regulation$323,964
R01 · FY2020 · DE · contact PI
Molecular Basis of KSHV oncogenesis$316,934
R35 · FY2020 · CA · contact PI
KSHVmediated regulation of proline metabolism$313,840
R01 · FY2020 · DE · contact PI
KSHVmediated regulation of proline metabolism$188,434
R01 · FY2020 · DE · contact PI
KSHV Epigenetic Regulation$110,045
R01 · FY2020 · DE · contact PI
Infection and Rapid Transmission of SARS-C0V-2 in Ferrets$26,293
R01 · FY2020 · AI · contact PI
Molecular Basis of KSHV oncogenesis$915,321
R35 · FY2019 · CA · contact PI
Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV$750,427
R01 · FY2019 · AI
SFTSV nonstructural protein NSs-mediated immunopathogenesis$617,831
R01 · FY2019 · AI · contact PI
KSHVmediated regulation of proline metabolism$506,956
R01 · FY2019 · DE · contact PI
Role of TRIM9 brain-specific E3 ubiquitin ligase in Alzheimerâs disease$247,500
R01 · FY2019 · AI · contact PI
Regulation of lymphangiogenesis by KSHV vIRF3$124,302
R21 · FY2019 · DE · contact PI
Regulation of lymphangiogenesis by KSHV vIRF3$78,860
R21 · FY2019 · DE · contact PI
Molecular Basis of KSHV oncogenesis$943,324
R35 · FY2018 · CA · contact PI
Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV$776,704
R01 · FY2018 · AI
SFTSV nonstructural protein NSs-mediated immunopathogenesis$634,081
R01 · FY2018 · AI · contact PI
TRIM9-mediated anti-viral immune pathway$412,500
R01 · FY2018 · AI · contact PI
Regulation of lymphangiogenesis by KSHV vIRF3$247,500
R21 · FY2018 · DE · contact PI
Role of autophagy for Zika virus lifecycle$206,250
R21 · FY2018 · AI · contact PI
KSHV Persistence and Pathogenesis$1,472,214
P01 · FY2017 · CA · contact PI
Molecular Basis of KSHV oncogenesis$958,770
R35 · FY2017 · CA · contact PI
Role of viral BCI-2 mediated anti-apoptosis and-autophagy$459,142
R01 · FY2017 · AI · contact PI
TRIM9-mediated anti-viral immune pathway$412,500
R01 · FY2017 · AI · contact PI
KSHV Epigenetic Regulation$412,500
R01 · FY2017 · DE · contact PI
Roles of Nucleotide Metabolic Control in KSHV Persistence$339,204
P01 · FY2017 · CA · contact PI
Roles of the K3 and K5 in KSHV Persistence and Pathogenesis$339,204
P01 · FY2017 · CA · contact PI
Roles of MicroRNAs in KSHV Persistence and Pathogenesis$339,204
P01 · FY2017 · CA · contact PI
Role of autophagy for Zika virus lifecycle$247,500
R21 · FY2017 · AI · contact PI
Core Director: Paula M. Cannon$206,728
P01 · FY2017 · CA · contact PI
Core Director: Hye-Ra-Lee$140,496
P01 · FY2017 · CA · contact PI
Core Diector: Jae U Jung$107,378
P01 · FY2017 · CA · contact PI
KSHV Persistence and Pathogenesis$1,472,214
P01 · FY2016 · CA · contact PI
Molecular Basis of KSHV oncogenesis$652,549
R35 · FY2016 · CA · contact PI
Role of viral BCI-2 mediated anti-apoptosis and-autophagy$452,259
R01 · FY2016 · AI · contact PI
TRIM9-mediated anti-viral immune pathway$412,500
R01 · FY2016 · AI · contact PI
KSHV Epigenetic Regulation$412,500
R01 · FY2016 · DE · contact PI
Molecular Basis of Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis$376,438
R01 · FY2016 · CA · contact PI
Roles of the K3 and K5 in KSHV Persistence and Pathogenesis$363,961
P01 · FY2016 · CA · contact PI
Roles of Nucleotide Metabolic Control in KSHV Persistence$363,960
P01 · FY2016 · CA · contact PI
Roles of MicroRNAs in KSHV Persistence and Pathogenesis$363,960
P01 · FY2016 · CA · contact PI
Core Director: Paula M. Cannon$148,072
P01 · FY2016 · CA · contact PI
Core Diector: Jae U Jung$125,689
P01 · FY2016 · CA · contact PI
Core Director: Hye-Ra-Lee$106,572
P01 · FY2016 · CA · contact PI
KSHV Persistence and Pathogenesis$1,472,214
P01 · FY2015 · CA · contact PI
Role of viral BCI-2 mediated anti-apoptosis and-autophagy$477,601
R01 · FY2015 · AI · contact PI
KSHV Epigenetic Regulation$412,500
R01 · FY2015 · DE · contact PI
TRIM9-mediated anti-viral immune pathway$411,979
R01 · FY2015 · AI · contact PI
When Autophagy Meets Phagocytosis$398,925
R01 · FY2015 · HL · contact PI
Molecular Basis of Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis$391,282
R01 · FY2015 · CA · contact PI
Roles of the K3 and K5 in KSHV Persistence and Pathogenesis$363,961
P01 · FY2015 · CA · contact PI
Roles of Nucleotide Metabolic Control in KSHV Persistence$363,960
P01 · FY2015 · CA · contact PI
Roles of MicroRNAs in KSHV Persistence and Pathogenesis$363,960
P01 · FY2015 · CA · contact PI
KSHV RTA: more than viral replication$295,985
R01 · FY2015 · CA · contact PI
Core Director: Paula M. Cannon$148,072
P01 · FY2015 · CA · contact PI
Core Diector: Jae U Jung$125,689
P01 · FY2015 · CA · contact PI
Core Director: Hye-Ra-Lee$106,572
P01 · FY2015 · CA · contact PI
KSHV Persistence and Pathogenesis$1,424,082
P01 · FY2014 · CA · contact PI
Role of viral BCI-2 mediated anti-apoptosis and-autophagy$468,944
R01 · FY2014 · AI · contact PI
KSHV Epigenetic Regulation$411,250
R01 · FY2014 · DE · contact PI
When Autophagy Meets Phagocytosis$381,710
R01 · FY2014 · HL · contact PI
Roles of the K3 and K5 in KSHV Persistence and Pathogenesis$352,383
P01 · FY2014 · CA · contact PI
Roles of MicroRNAs in KSHV Persistence and Pathogenesis$352,380
P01 · FY2014 · CA · contact PI
Roles of Nucleotide Metabolic Control in KSHV Persistence$352,380
P01 · FY2014 · CA · contact PI
Molecular basis for Herpesvirus saimiri oncogenicity$331,599
R01 · FY2014 · CA · contact PI
KSHV RTA: more than viral replication$307,080
R01 · FY2014 · CA · contact PI
KSHV vaccine development$242,548
R21 · FY2014 · AI · contact PI
Core Director: Paula M. Cannon$142,969
P01 · FY2014 · CA · contact PI
Core Diector: Jae U Jung$121,256
P01 · FY2014 · CA · contact PI
Core Director: Hye-Ra-Lee$102,714
P01 · FY2014 · CA · contact PI
Host-pathogen competition in IFN mediated antiviral defense$1,820,077
U19 · FY2013 · AI · contact PI
KSHV Persistence and Pathogenesis$1,463,663
P01 · FY2013 · CA · contact PI
KSHV Epigenetic Regulation$410,000
R01 · FY2013 · DE · contact PI
When Autophagy Meets Phagocytosis$385,560
R01 · FY2013 · HL · contact PI
Role of viral BCI-2 mediated anti-apoptosis and-autophagy$385,500
R01 · FY2013 · AI · contact PI
Roles of the K3 and K5 in KSHV Persistence and Pathogenesis$362,536
P01 · FY2013 · CA · contact PI
Roles of Nucleotide Metabolic Control in KSHV Persistence$362,535
P01 · FY2013 · CA · contact PI
Roles of MicroRNAs in KSHV Persistence and Pathogenesis$362,535
P01 · FY2013 · CA · contact PI
Molecular basis for Herpesvirus saimiri oncogenicity$338,655
R01 · FY2013 · CA · contact PI
KSHV RTA: more than viral replication$281,656
R01 · FY2013 · CA · contact PI
RIG-I and TRIM 25 mediated immune surveillance against viruses$279,412
U19 · FY2013 · AI · contact PI
KSHV vaccine development$205,000
R21 · FY2013 · AI · contact PI
Core Director: Paula M. Cannon$146,647
P01 · FY2013 · CA · contact PI
Core Diector: Jae U Jung$124,263
P01 · FY2013 · CA · contact PI
Core Director: Hye-Ra-Lee$105,147
P01 · FY2013 · CA · contact PI
Administrative Core$76,202
U19 · FY2013 · AI · contact PI
Host-pathogen competition in IFN mediated antiviral defense$1,936,252
U19 · FY2012 · AI · contact PI
When Autophagy Meets Phagocytosis$389,500
R01 · FY2012 · HL · contact PI
Molecular basis for Herpesvirus saimiri oncogenicity$343,243
R01 · FY2012 · CA · contact PI
Non-Human Primate Model for KSHV Persistent Infection$328,090
P01 · FY2012 · DE · contact PI
Molecular Basis of Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis$324,583
R01 · FY2012 · CA · contact PI
KSHV RTA: more than viral replication$320,049
R01 · FY2012 · CA · contact PI
RIG-I and TRIM 25 mediated immune surveillance against viruses$305,962
U19 · FY2012 · AI · contact PI
Administrative Core$82,959
U19 · FY2012 · AI · contact PI
Host-pathogen competition in IFN mediated antiviral defense$1,932,378
U19 · FY2011 · AI · contact PI
When Autophagy Meets Phagocytosis$405,000
R01 · FY2011 · HL · contact PI
Role of viral BCI-2 mediated anti-apoptosis and-autophagy$391,803
R01 · FY2011 · AI · contact PI
Molecular basis for Herpesvirus saimiri oncogenicity$362,787
R01 · FY2011 · CA · contact PI
Non-Human Primate Model for KSHV Persistent Infection$337,934
P01 · FY2011 · DE · contact PI
Molecular Basis of Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis$312,161
R01 · FY2011 · CA · contact PI
KSHV RTA: more than viral replication$303,371
R01 · FY2011 · CA · contact PI
RIG-I and TRIM 25 mediated immune surveillance against viruses$302,179
U19 · FY2011 · AI · contact PI
Administrative Core$117,470
U19 · FY2011 · AI · contact PI
Host-pathogen competition in IFN mediated antiviral defense$1,939,033
U19 · FY2010 · AI · contact PI
Live-attenuated KSHV as vaccine candidate$500,000
RC2 · FY2010 · CA · contact PI
Peptide-mediated immunotherapy of KSHV-associated malignancy.$498,591
RC1 · FY2010 · CA · contact PI
RIG-I and TRIM25 mediated immune surveillance against virus$477,023
R01 · FY2010 · AI · contact PI
Host-pathogen competition in IFN mediated antiviral defense$414,375
U19 · FY2010 · AI · contact PI
Role of viral BCI-2 mediated anti-apoptosis and-autophagy$395,761
R01 · FY2010 · AI · contact PI
Molecular basis for Herpesvirus saimiri oncogenicity$355,090
R01 · FY2010 · CA · contact PI
Non-Human Primate Model for KSHV Persistent Infection$351,948
P01 · FY2010 · DE · contact PI
Molecular Basis of Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis$334,794
R01 · FY2010 · CA · contact PI
RIG-I and TRIM 25 mediated immune surveillance against viruses$302,910
U19 · FY2010 · AI · contact PI
Administrative Core$118,657
U19 · FY2010 · AI · contact PI
Host-pathogen competition in IFN mediated antiviral defense$1,969,262
U19 · FY2009 · AI · contact PI
Live-attenuated KSHV as vaccine candidate$500,000
RC2 · FY2009 · CA · contact PI
Peptide-mediated immunotherapy of KSHV-associated malignancy.$494,752
RC1 · FY2009 · CA · contact PI
RIG-I and TRIM25 mediated immune surveillance against virus$448,250
R01 · FY2009 · AI · contact PI
Role of viral BCI-2 mediated anti-apoptosis and-autophagy$399,758
R01 · FY2009 · AI · contact PI
Non-Human Primate Model for KSHV Persistent Infection$357,330
P01 · FY2009 · DE · contact PI
Molecular Basis of Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis$323,675
R01 · FY2009 · CA · contact PI
KSHV RTA: more than viral replication$305,244
R01 · FY2009 · CA · contact PI
RIG-I and TRIM 25 mediated immune surveillance against viruses$304,101
U19 · FY2009 · AI · contact PI
Herpesvirus saimiri TIP$299,169
R01 · FY2009 · CA · contact PI
Administrative Core$124,669
U19 · FY2009 · AI · contact PI
Non-Human Primate Model for KSHV Persistent Infection$584,330
P01 · FY2008 · DE · contact PI
Role of viral BCI-2 mediated anti-apoptosis and-autophagy$399,758
R01 · FY2008 · AI · contact PI
Molecular basis for Herpesvirus saimiri oncogenicity$342,420
R01 · FY2008 · CA · contact PI
Molecular Basis of Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis$336,688
R01 · FY2008 · CA · contact PI
KSHV RTA: more than viral replication$305,244
R01 · FY2008 · CA · contact PI
Cell growth deregulation by KSHV protein$285,151
R01 · FY2008 · CA · contact PI
Herpesvirus saimiri TIP$274,719
R01 · FY2008 · CA · contact PI
EDUCATION AND TRAINING$162,209
P51 · FY2008 · RR · contact PI
INHIBITION OF RETROMER BY HVS TIP$32,442
P51 · FY2008 · RR · contact PI
HVS STP-C ONCOPROTEIN TARGETS TRAFS TO INDUCE CELL GROWTH TRANSFORMATION$32,442
P51 · FY2008 · RR · contact PI
TUMOR VIROLOGY SAMPLE DISTRIBUTION$32,442
P51 · FY2008 · RR · contact PI
TRIM25 RING-FINGER UBIQUITIN LIGASE RIG-I MEDIATED ANTI-VIRAL ROLE$32,442
P51 · FY2008 · RR · contact PI
Role of viral BCI-2 mediated anti-apoptosis and-autophagy$433,750
R01 · FY2007 · AI · contact PI
Molecular Basis of KSHV Pathogenesis$338,914
R01 · FY2007 · CA · contact PI
KSHV RTA: more than viral replication$316,480
R01 · FY2007 · CA · contact PI
Cell growth deregulation by KSHV protein$315,086
R01 · FY2007 · CA · contact PI
Herpesvirus saimiri TIP$284,831
R01 · FY2007 · CA · contact PI
Molecular basis for Herpesvirus saimiri oncogenicity$210,546
R01 · FY2007 · CA · contact PI
Molecular basis for Herpesvirus saimiri oncogenicity$144,674
R01 · FY2007 · CA · contact PI
SAIMIRI TRANSFORMING PROTEINS, HERPESVIRUS SAIMIRI (HVS$31,562
P51 · FY2007 · RR · contact PI
TRIM25 IS ESSENTIAL FOR RIG-I-MEDIATED ANTIVIRAL ACTIVITY$31,562
P51 · FY2007 · RR · contact PI
TUMOR VIROLOGY SAMPLE DISTRIBUTION$31,561
P51 · FY2007 · RR · contact PI
Molecular basis for Herpesvirus saimiri oncogenicity$395,727
R01 · FY2006 · CA · contact PI
Molecular Basis of KSHV Pathogenesis$371,983
R01 · FY2006 · CA · contact PI
KSHV RTA: more than viral replication$325,932
R01 · FY2006 · CA · contact PI
Cell growth deregulation by KSHV protein.$304,477
R01 · FY2006 · CA · contact PI
Herpesvirus saimiri TIP$293,338
R01 · FY2006 · CA · contact PI
EDUCATION AND TRAINING$55,933
P51 · FY2006 · RR · contact PI
Molecular basis for Herpesvirus saimiri oncogenicity$403,313
R01 · FY2005 · CA
Molecular Basis of KSHV Pathogenesis$357,435
R01 · FY2005 · CA
Cell growth deregulation by KSHV protein.$332,305
R01 · FY2005 · CA
KSHV RTA: more than viral replication$320,148
R01 · FY2005 · CA
Herpesvirus saimiri TIP$320,148
R01 · FY2005 · CA
A novel immune evasion strategy of KSHV K3 and K5$285,728
R01 · FY2005 · CA
KSHV K-BZIP REPRESSES GENE TRANSCRIPTION VIA SUMO MODIFICATION$160,742
P51 · FY2005 · RR
KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS K1 SIGNALOSOME$160,742
P51 · FY2005 · RR
INHIBITION OF TCR SIGNAL TRANSDUCTION BY HVS TIP$160,742
P51 · FY2005 · RR
EDUCATION AND TRAINING$100,272
P51 · FY2005 · RR
ACTIVATION OF CD21 AND CD23 GENE EXPRESSION BY KSHV RTA$77,924
P51 · FY2005 · RR